Karyopharm Therapeutics (KPTI) Payables (2012 - 2026)
Karyopharm Therapeutics (KPTI) posted Payables of $7.66 million for Q2 2026, up 195.0% from $2.6 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Payables came in at $4 million, down 21.6% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Payables was $5.11 million in FY2024 (+63.5%), $3.12 million in FY2023 (+12.6%), $2.77 million in FY2022 (+73.0%) and $1.6 million in FY2021 (-64.0%).
- The Q2 2026 figure stands as the highest quarterly Payables since Q1 2023.
- On a year-over-year basis, Payables increased in four of the last seven quarters, with growth averaging 107.6%.
- The strongest year-over-year quarter for Payables in the past five years was Q3 2024, with growth of 513.3%; the weakest was Q4 2021, with a decline of 64.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.62 Bn | 1,105.21 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 617.59 Bn | 536.12 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.69 Bn | 474.80 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 368.29 Bn | 322.67 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.79 Bn | 261.78 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 260.82 Bn | 234.50 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.14 Bn | 165.33 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.69 Bn | 116.33 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Karyopharm Therapeutics | 11.66 Mn | -214.76 Mn | 32.35 Mn | 7.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.66 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 5.39 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 3.12 Mn |
| Sep 30, 2023 | 943,000.00 |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 9.05 Mn |
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | 813,000.00 |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 881,000.00 |
| Jun 30, 2021 | 2.31 Mn |
API Access
Karyopharm Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();